Latest news
Outcome of 'Zeus' Trial Throws Wrench in Heart Disease Theory - NewserNewser · Sat, 08 Aug 2026 11:30:00 GMTNew heart drug targeting inflammation falls short in clinical trial - Cardiovascular BusinessCardiovascular Business · Thu, 06 Aug 2026 20:22:24 GMTZEUS Tells Us Inflammation Might Not Be the Answer - Cardiac WireCardiac Wire · Thu, 06 Aug 2026 10:22:53 GMTTokyo's Growth Market 250 Index Stumbles After Five-Day Rally, Weighed Down by U.S. Tech Weakness - finance.biggo.comfinance.biggo.com · Thu, 06 Aug 2026 07:25:00 GMTNovo Nordisk (CPSE:NOVO B) Reports Mixed ZEUS Phase 3 Results For Ziltivekimab - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 19:09:11 GMTZEUS Trial: Ziltivekimab Fails to Reduce MACE in ASCVD Patients - TCTMD.comTCTMD.com · Mon, 03 Aug 2026 17:05:08 GMTCiti keeps neutral on Novo Nordisk after heart drug trial fails, citing GLP-1 competition worries. - PluangPluang · Mon, 03 Aug 2026 16:38:46 GMTCiti says Novo selloff overdone but GLP-1 worries keep it on the sidelines - Proactive InvestorsProactive Investors · Mon, 03 Aug 2026 15:02:00 GMT